NNC0363-1063
- Generic Name
- NNC0363-1063
A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes
Phase 1
Recruiting
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- First Posted Date
- 2024-11-12
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 154
- Registration Number
- NCT06685185
- Locations
- 🇩🇪
Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath